Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines

Nutrition and Cancer

Volumn 45, Issue 2, 2003, Pages 247-255

  Vissac Sabatier, Cécile ^a   Bignon, Yves Jean ^a   Bernard Gallon, Dominique J ^a  

^a CENTRE JEAN PERRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; BRCA2 PROTEIN; CYCLOHEXIMIDE; DACTINOMYCIN; DAIDZEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; ISOFLAVONE; PHYTOESTROGEN;

AFFINITY CHROMATOGRAPHY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RISK; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; JAPAN; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOYBEAN; TUMOR SUPPRESSOR GENE;

GLYCINE MAX;

EID: 0043013225     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC4502_15     Document Type: Article

References (41)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71, 1994.
2. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, et al.: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090, 1994.
3. Claus EB, Risch N, and Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48, 232-242, 1991.
4. Foster KA, Harrington P, Kerr J, Russell P, DiCioccio RA, et al.: Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res 56, 3622-3625, 1996.
5. Miki Y, Katagiri T, Kasumi F, Yoshimoto T, and Nakamura Y: Mutation analysis in the BRCA2 gene in primary breast cancers. Nat Genet 13, 245-247, 1996.
6. Collins N, Wooster R, and Stratton MR: Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Br J Cancer 76, 1150-1156, 1997.
7. Bieche I, Nogues C, and Lidereau R: Overexpression of BRCA2 gene in sporadic breast tumours. Oncogene 18, 5232-5238, 1999.
8. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, et al.: Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792, 1995.
9. Bork P, Blomberg N, and Nilges M: Internal repeats in the BRCA2 protein sequence. Nat Genet 13, 22-23, 1996.
10. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, et al.: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12, 333-337, 1996.
11. Rajan JV, Wang M, Marquis ST, and Chodosh LA: Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA 93, 13078-13083, 1996.
12. Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, et al.: Cell cycle control of BRCA2. Cancer Res 56, 4590-4594, 1996.
13. Bertwistle D, Swift S, Marston NJ, Jackson LE, Crossland S, et al.: Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res 57, 5485-5488, 1997.
14. Rajan JV, Marquis ST, Gardner HP, and Chodosh LA: Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol 184, 385-401, 1997.
15. Maldonado E, Shiekhattar R, Sheldon M, Cho H, Drapkin R, et al.: A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature 381, 86-89, 1996.
16. Fuks F, Milner J, and Kouzarides T: BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene 17, 2531-2534, 1998.
17. Siddique H, Zou JP, Rao VN, and Reddy ES: The BRCA2 is a histone acetyltransferase. Oncogene 16, 2283-2285, 1998.
18. Ingram D, Sanders K, Kolybaba M, and Lopez D: Case-control study of phyto-oestrogens and breast cancer. Lancet 350, 990-994, 1997.
19. Barnes S, Grubbs C, Setchell KD, and Carlson J: Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 347, 239-253, 1990.
20. Adlercreutz CH, Goldin BR, Gorbach SL, Hockerstedt KA, Watanabe S, et al.: Soybean phytoestrogen intake and cancer risk. J Nutr 125, 757S-770S, 1995.
21. Adlercreutz H: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103(Suppl 7), 103-112, 1995.
22. Messina M, Barnes S, and Setchell KD. Phyto-oestrogens and breast cancer. Lancet 350, 971-972, 1997.
23. Barnes S, Peterson G, Grubbs C, and Setchell K: Potential role of dietary isoflavones in the prevention of cancer. Adv Exp Med Biol 354, 135-147, 1994.
24. Barnes S and Peterson TG: Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 208, 103-108, 1995.
25. Constantinou A and Huberman E: Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc Soc Exp Biol Med 208, 109-115, 1995.
26. Soule HD, Vazguez J, Long A, Albert S, and Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. JNCI 51, 1409-1416, 1973.
27. Cailleau R, Young R, Olive M, and Reeves WJ Jr: Breast tumor cell lines from pleural effusions. JNCI 53, 661-674, 1974.
28. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, et al.: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50, 6075-6086, 1990.
29. Parvin JD: BRCA1 at a branch point. Proc Natl Acad Sci USA 98, 5952-5954, 2001.
30. Paull TT, Cortez D, Bowers B, Elledge SI, and Gellert M: From the cover: direct DNA binding by Brca1. Proc Natl Acad Sci USA 98, 6086-6091, 2001.
31. Arnold SF and Notides AC: An antiestrogen: a phosphotyrosyl peptide that blocks dimerization of the human estrogen receptor. Proc Natl Acad Sci USA 92, 7475-7479, 1995.
32. Hizel C, Maurizis JC, Rio P, Communal Y, Chassagne J, et al.: Isolation, purification and quantification of BRCA1 protein from tumour cells by affinity perfusion chromatography. J Chromatogr B 721, 163-170, 1999.
33. Vissac C, Lemery D, Le Corre L, Fustier P, Dechelotte P, et al.: Presence of BRCA1 and BRCA2 proteins in human milk fat globules after delivery. Biochim Biophys Acta 1586, 50-56, 2002.
34. Blagosklonny MV, An WG, Melillo G, Nguyen P, Trepel JB et al.: Regulation of BRCA1 by protein degradation. Oncogene 18, 6460-6468, 1999.
35. Spillman MA and Bowcock AM: BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 13, 1639-1645, 1996.
36. Kinjo J: Phytoestrogens. Nippon Rinsho 58, 2434-2438, 2000.
37. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, and Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93, 5925-5930, 1996.
38. Rouayrenc JF, Vignon F, Bringer J, and Pujol P: Non-genomic steroid effects: estrogen action revisited. Ann Endocrinol 61, 517-523, 2000.
39. Messina MJ, Persky V, Setchell KD, and Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21, 113-131, 1994.
40. Vonderhaar BK: Prolactin: the forgotten hormone of human breast cancer. Pharmacol Ther 79, 169-178, 1998.
41. Mosselman S, Polman J, and Dijkerma R: ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392, 49-53, 1996.